ArticleJTCVS techniques2026
Early clinical experience with a novel single-port robotic system for mediastinal tumor resection: A feasibility and safety assessment.
Article in JTCVS techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the feasibility and perioperative safety of anterior mediastinal tumor resection using a flexible single-port robotic system (SR-ENS-600) via a single subxiphoid approach. Methods: This prospective single-center feasibility study included the first 4 consecutive patients undergoing anterior mediastinal tumor resection with the SR-ENS-600 system. The primary end point was successful completion of resection without conversion or major device malfunction. Secondary end points included operative metrics, intraoperative safety, and 30-day postoperative outcomes. Results: All procedures were completed via a single subxiphoid approach without conversion or device malfunction (technical success rate: 100%). Robotic manipulation time ranged from 62 to 116 minutes, and total operative time ranged from 89 to 131 minutes. Docking time decreased from 6 minutes in the first case to 2 to 3 minutes in subsequent cases. No intraoperative complications occurred. No Clavien-Dindo grade III or greater complications, reoperations, or 30-day readmissions were observed. Conclusions: Early clinical experience suggests that flexible single-port robotic resection of anterior mediastinal tumors via a subxiphoid approach is feasible and perioperatively safe in selected patients. Further evaluation in larger cohorts is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.